These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30374773)

  • 1. Interventional closure vs. medical therapy of patent foramen ovale for secondary prevention of stroke: updated meta-analysis.
    Shah SR
    Clin Res Cardiol; 2019 Apr; 108(4):452. PubMed ID: 30374773
    [No Abstract]   [Full Text] [Related]  

  • 2. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
    Khan AR; Bin Abdulhak AA; Sheikh MA; Khan S; Erwin PJ; Tleyjeh I; Khuder S; Eltahawy EA
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1316-23. PubMed ID: 24139929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventional closure vs. medical therapy of patent foramen ovale for secondary prevention of stroke: updated meta-analysis.
    Vukadinović D; Schirmer SH; Vukadinović AN; Ukena C; Scheller B; Mahfoud F; Böhm M
    Clin Res Cardiol; 2019 Feb; 108(2):157-166. PubMed ID: 30051178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent Foramen Ovale: Stroke and Device Closure.
    Suradi HS; Hijazi ZM
    Cardiol Clin; 2016 May; 34(2):231-40. PubMed ID: 27150171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Invasive closure of patent foramen ovale without benefits].
    Pommer P
    Dtsch Med Wochenschr; 2016 Jan; 141(1):16. PubMed ID: 27097386
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Stroke: Meta-Analysis of Randomised Trials.
    Wang TKM; Wang MTM; Ruygrok P
    Heart Lung Circ; 2019 Apr; 28(4):623-631. PubMed ID: 29602754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
    Wiktor DM; Carroll JD
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent Foramen Ovale after Cryptogenic Stroke - Assessing the Evidence for Closure.
    Farb A; Ibrahim NG; Zuckerman BD
    N Engl J Med; 2017 Sep; 377(11):1006-1009. PubMed ID: 28902595
    [No Abstract]   [Full Text] [Related]  

  • 10. Current Dataset for Patent Foramen Ovale Closure in Cryptogenic Stroke: Randomized Clinical Trials and Observational Studies.
    Odunukan OW; Price MJ
    Interv Cardiol Clin; 2017 Oct; 6(4):525-538. PubMed ID: 28886843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.
    Akobeng AK; Abdelgadir I; Boudjemline Y; Hijazi ZM
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):165-173. PubMed ID: 29602258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
    Mas JL; Derumeaux G; Guillon B; Massardier E; Hosseini H; Mechtouff L; Arquizan C; Béjot Y; Vuillier F; Detante O; Guidoux C; Canaple S; Vaduva C; Dequatre-Ponchelle N; Sibon I; Garnier P; Ferrier A; Timsit S; Robinet-Borgomano E; Sablot D; Lacour JC; Zuber M; Favrole P; Pinel JF; Apoil M; Reiner P; Lefebvre C; Guérin P; Piot C; Rossi R; Dubois-Randé JL; Eicher JC; Meneveau N; Lusson JR; Bertrand B; Schleich JM; Godart F; Thambo JB; Leborgne L; Michel P; Pierard L; Turc G; Barthelet M; Charles-Nelson A; Weimar C; Moulin T; Juliard JM; Chatellier G;
    N Engl J Med; 2017 Sep; 377(11):1011-1021. PubMed ID: 28902593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent foramen ovale and cryptogenic stroke: many unanswered questions.
    Roth C; Alli O
    Cleve Clin J Med; 2014 Jul; 81(7):417-24. PubMed ID: 24987042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter closure of patent foramen ovale following cryptogenic stroke: An updated meta-analysis of randomized controlled trials.
    Riaz H; Khan MS; Schenone AL; Waheed AA; Khan AR; Krasuski RA
    Am Heart J; 2018 May; 199():44-50. PubMed ID: 29754665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders.
    Collado FMS; Poulin MF; Murphy JJ; Jneid H; Kavinsky CJ
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29910192
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials.
    Abdelaziz HK; Saad M; Abuomara HZ; Nairooz R; Pothineni NVK; Madmani ME; Roberts DH; Mahmud E
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):176-186. PubMed ID: 29726616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent foramen ovale closure to prevent secondary neurologic events.
    Jasper R; Blankenship JC
    Eur J Intern Med; 2017 Oct; 44():1-11. PubMed ID: 28684051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prevention of ischaemic stroke.
    Muller C; Roizman M; Wong A
    Intern Med J; 2019 Oct; 49(10):1221-1228. PubMed ID: 31602772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
    Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
    N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual Shunt after Patent Foramen Ovale Device Closure in Patients With Cryptogenic Stroke: Serial Bubble Contrast Transesophageal Echocardiography Data.
    Moon J; Kim M; Oh PC; Shin DH; Park HM; Jo YY; Lee JS; Kang WC
    J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):347-353. PubMed ID: 30396838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.